---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-013119"
form_type: "8-K"
ticker: "ULBI"
cik: "0000875657"
company_name: "ULTRALIFE CORP"
filed_at: "2024-04-25T23:59:59+00:00"
generated_at: "2026-06-03T08:56:41.292995+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Ultralife Q1 sales up 31.4% to $41.9M; GAAP EPS $0.18 vs -$0.02 YoY

## Summary
- Revenue $41.9M (+31.4% YoY); government/defense sales +83.4%, medical battery sales +54.7%.
- GAAP EPS $0.18 vs net loss $0.02; adjusted EPS $0.21. Operating income $4.1M vs breakeven.
- Gross margin 27.4% vs 23.3% YoY; Battery & Energy margin 25.7% vs 22.9%.
- Backlog $97.4M; adjusted EBITDA $5.2M (12.5% of sales) vs $1.2M (3.6%).
- CEO cites gross margin initiatives and core product demand; expects profitable growth and cash flow.

## SEC filing metadata
- accession: 0001437749-24-013119
- form_type: 8-K
- ticker: ULBI
- cik: 0000875657
- company_name: ULTRALIFE CORP
- filed_at: 2024-04-25T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/875657/000143774924013119/0001437749-24-013119-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/875657/000143774924013119/ulbi20240424_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-013119
- JSON: https://secwatch.observer/filing/0001437749-24-013119.json
- Plain text: https://secwatch.observer/filing/0001437749-24-013119.txt

## Key facts
- Earnings Releases
  ULTRALIFE CORP reported financial results for first quarter ended March 31, 2024.
  - Period: first quarter ended March 31, 2024
  - Result: reported results
  source text: On April 25, 2024, Ultralife Corporation issued a press release regarding the financial results for its first quarter ended March 31, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/875657/000143774924013119/0001437749-24-013119-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.